Acquired Immunodeficiency Syndrome
📧 Sign up to get email alerts when something new happens for Acquired Immunodeficiency Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: HIV/STD Risk and PrEP Implementation Messaging Among Gay, Bisexual, and Other Men Who Have Sex With Men
An Emory University-sponsored clinical trial assessing HIV/sexually transmitted infection risk and PrEP implementation messaging among gay, …
-
CLINICAL_TRIALS trial_result · 2025-08-17Clinical Trial Update: Testing an Integrated Bio-Behavioral Primary HIV Prevention Intervention Among High-Risk People Who Use Drugs [NA]
This clinical trial update reports completion of a study evaluating an integrated bio-behavioral HIV prevention intervention among high-risk…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: BRAZILIAN REGISTRY OF CHRONIC NON-COMMUNICABLE DISEASES IN PEOPLE LIVING WITH HIV/AIDS
This is a clinical trial registry update for the Brazilian Registry of Chronic Non-Communicable Diseases in people living with HIV/AIDS, not…
-
CLINICAL_TRIALS trial_result · 2025-07-30Clinical Trial Update: High-quality COPD Care for People With Immune Dysfunction Through Proactive E-consults [NA]
A completed clinical trial update examining whether proactive e-consults improve high-quality COPD care for people with immune dysfunction, …
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: Safety & Efficacy of Dual Therapy With Raltegravir/Lamivudine [Phase 3]
Phase 3 trial assessing the safety and efficacy of dual therapy with raltegravir and lamivudine in AIDS. Results have been posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: Study to Evaluate the Safety and Immunogenicity of an HIV-1 Vaccine Regimen of Adjuvanted UVAX-1107 Followed by Adjuvanted UVAX-1107 or Adjuvanted UVAX-1197 in Healthy Subjects Aged 25-55 Years. [EARLY_Phase 1]
A Phase 1 study evaluating the safety and immunogenicity of an HIV-1 vaccine regimen (UVAX-1107 with adjuvant, followed by UVAX-1107 or UVAX…
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men [NA]
A completed clinical trial evaluated self-test strategies and linkage incentives to improve ART and PrEP uptake among men; results were post…
-
CLINICAL_TRIALS research · 2025-02-19Clinical Trial Update: Community Intervention for HIV Testing & Care Linkage Among Young MSM in Bulgaria [NA]
This update notes the completion of a clinical trial evaluating a community-based intervention to increase HIV testing and linkage to care a…
-
CLINICAL_TRIALS research · 2025-02-04Clinical Trial Update: Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS [Phase 3]
Phase 3 clinical trial assessing the efficacy and safety of high-dose liposomal amphotericin B for disseminated Histoplasma capsulatum infec…
-
FDA approval · 2024-12-18FDA Approved: RETROVIR — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for RETROVIR (Zidovudine) filed by ViiV Healthcare Company.
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Economic Navigation and Strengthening to Research Unrestricted Services for Transgender Women (ENTRUST) [NA]
Clinical trial update for ENTRUST, a University of Central Florida study on economic navigation and strengthened unrestricted services for t…
-
FDA approval · 2024-11-11FDA Approved: RETROVIR — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for RETROVIR (zidovudine) submitted by ViiV Healthcare Company.
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: Standardized Patients to Measure and Address Intersectional Stigma [NA]
The University of Minnesota completed a clinical trial using standardized patients to measure and address intersectional stigma related to H…
-
CLINICAL_TRIALS trial_result · 2024-04-19Clinical Trial Update: Immunologic Response to Kansui in Treated HIV+ Individuals: a Dose Escalation Study [Phase 1]
Phase 1 dose-escalation study evaluating immunologic response to Kansui in treated HIV+ individuals; the study is terminated with results po…
-
CLINICAL_TRIALS trial_result · 2023-12-14Clinical Trial Update: Impact of a Dolutegravir-based Regimen on Early Mortality of AIDS Patients [Phase 2, Phase 3]
A clinical trial evaluating a dolutegravir-based regimen showed results in severely immunocompromised HIV patients, with completed Phase 2 a…
-
FDA approval · 2023-12-13FDA Approved: APRETUDE — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for APRETUDE (cabotegravir) filed by ViiV Healthcare Company, resulting in an updated labeling/indic…
-
CLINICAL_TRIALS trial_result · 2023-09-18Clinical Trial Update: A Sub-study of Cabotegravir (CAB) and Rilpivirine (RPV) in Human Immunodeficiency Viruses (HIV)-Infected Participants [Phase 3]
A Phase 3 sub-study evaluating cabotegravir and rilpivirine in HIV-1 infected participants has completed with posted results.
-
FDA approval · 2023-04-05FDA Approved: LAMIVUDINE AND ZIDOVUDINE — Supplemental Application (Exelan Pharmaceuticals Inc.)
FDA approved a supplemental application for Lamivudine and Zidovudine from Exelan Pharmaceuticals, confirming continued availability of this…
-
FDA approval · 2023-03-28FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Supplemental Application (QUALLENT PHARMACEUTICALS HEALTH LLC)
The FDA granted a supplemental approval for the emtricitabine and tenofovir disoproxil fumarate product from Quallent Pharmaceuticals Health…
-
FDA approval · 2022-12-15FDA Approved: NORVIR — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for NORVIR (ritonavir) from AbbVie, resulting in updated labeling for the product. This action r…
-
CLINICAL_TRIALS trial_result · 2022-08-30Clinical Trial Update: Vicriviroc in HIV-Treatment Experienced Subjects (Study P04889AM8)(COMPLETED) [Phase 3]
Phase 3 trial update for vicriviroc in treatment-experienced HIV patients; study completed.
-
CLINICAL_TRIALS trial_result · 2022-08-24Clinical Trial Update: Perturbing of HIV Reservoir With Immune Stimulation [NA]
A completed clinical trial investigating immune stimulation to perturb the HIV reservoir, with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-08-09Clinical Trial Update: Efficacy and Tolerability of DTG Plus 3TC in HIV Infected Adults With Virologically Suppression and TDF Toxicity [Phase 4]
Phase 4 study assessing the efficacy and tolerability of dolutegravir plus lamivudine in HIV-infected adults with virologic suppression and …
-
CLINICAL_TRIALS trial_result · 2022-07-12Clinical Trial Update: An Enhanced Package of Care to Reduce Reduce Mortality in Advanced HIV Disease [Phase 3]
Phase 3 trial evaluating an enhanced package of care to reduce mortality in advanced HIV disease; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2022-05-18Clinical Trial Update: The HIV Functional Cure Potential of UB-421 in ART Stabilized HIV-1 Patients [Phase 2]
A Phase 2 clinical trial update evaluating UB-421 for functional cure potential in ART-stabilized HIV-1 patients.